Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

One of the children was undergoing cancer treatment and one of the mothers is pregnant. Both families had lived in the country for years and had ties to their communities, according to the ...

“We should be doing all that we can to protect this first-line treatment and to ensure that the worst-case scenario of increased drug resistance projected by this UCL modelling exercise does not ...

Merck (NYSE:MRK) shares inched higher on Friday after Summit Therapeutics (NASDAQ:SMMT) announced the latest survival data related to its lung cancer therapy, ivonescimab, developed with Chinese ...

New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study. The drug, ivonescimab, was approved for previously untreated patients with ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration ... Tablets is indicated for the treatment of newly diagnosed adults ...

Veteran broadcaster Darren Scott recently opened up about his ongoing battle with cancer and mounting medical ... Africa to work in order to fund his treatment. “I’m back in South Africa ...

The Food and Drug Administration (FDA ... investigating this combination as a first-line treatment option for KRAS G12C metastatic colorectal cancer, he added. * CodeBreaK 300 was not designed ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor drugs ... cancer med Kisqali and AstraZeneca on its breast cancer ...

(Reuters) -Bristol Myers Squibb reported higher-than-expected first-quarter revenue on Thursday and raised its full-year forecast due to growth from its portfolio of drugs that spur a patient's immune ...

In January, the Food and Drug Administration (FDA ... this combination as a first-line treatment option for KRAS G12C metastatic colorectal cancer, he added. More information: Filippo Pietrantonio ...